Cures Acceleration Network
In recent years, the pharmaceutical industry has focused its efforts on the development of "blockbuster" drugs for conditions like hypertension or high cholesterol that will be assured a large market once they are approved. But not all treatments can be "blockbuster drugs" in terms of their lucrative profit potential, and we need to make sure we're incentivizing the development of life-saving treatments for diseases and conditions that can improve and preserve the lives of all Americans. To help push us in that direction, I co-sponsored an amendment (#2866) authored by Senator Arlen Specter of Pennsylvania, which was successfully included in the Senate health reform bill signed into law by President Obama. This amendment is designed to set up a new public-private program at the National Institutes of Health, which would provide grants to encourage companies to develop drugs and treatments that may not be huge money-makers.
If you have further questions about this or any other issue, please contact me with your concerns.
What I'm Working On: